ARCHIVES

NCI, FDA Courting Drug Sponsors To Add Clinical Trials To PDQ Database

This article is from The Cancer Letter archive.

Vol. 22 No. 39 | October 11, 1996

Download PDF Visit The Full Archive

Related Articles

FDA Advisors Recommend Approval Of Taxol for Node-Positive Breast Cancer

September 24, 1999

FASEB Report On NIH Funding Urges Sustained Growth In Fiscal Year 2011

April 16, 2010

Combination Radiation/Vaccine May Benefit Some Patients

April 29, 2005

Advisers Fume Over Preventions Budget Cut; NIH Probably Did It

May 22, 1992

Ramucirumab Improves Overall Survival, Progression-Free Survival in Phase III Trial

October 26, 2012

NCI to Ask Cancer Panel, NCAB, to Help Respond To Request for Review Of National Cancer Program

December 4, 1992